|
Volumn 11, Issue 6, 2007, Pages 801-804
|
Clostridium difficile.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
ANTIINFLAMMATORY AGENT;
BECLOMETASONE;
BUDESONIDE;
IMMUNOSUPPRESSIVE AGENT;
METRONIDAZOLE;
TACROLIMUS;
VANCOMYCIN;
BIOPSY;
CASE REPORT;
CLOSTRIDIUM DIFFICILE;
COLONOSCOPY;
FECES;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
INFECTION CONTROL;
MALE;
METHODOLOGY;
MICROBIOLOGY;
MIDDLE AGED;
MYELOFIBROSIS;
ONCOLOGY NURSING;
PHYSIOLOGY;
PSEUDOMEMBRANOUS COLITIS;
REVIEW;
RISK FACTOR;
ULTRASTRUCTURE;
ANTI-INFECTIVE AGENTS;
ANTI-INFLAMMATORY AGENTS;
BECLOMETHASONE;
BIOPSY;
BUDESONIDE;
CLOSTRIDIUM DIFFICILE;
COLONOSCOPY;
ENTEROCOLITIS, PSEUDOMEMBRANOUS;
FECES;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INFECTION CONTROL;
MALE;
METRONIDAZOLE;
MIDDLE AGED;
MYELOFIBROSIS;
ONCOLOGIC NURSING;
RISK FACTORS;
TACROLIMUS;
VANCOMYCIN;
|
EID: 39149090013
PISSN: 10921095
EISSN: None
Source Type: Journal
DOI: 10.1188/07.CJON.801-804 Document Type: Review |
Times cited : (1)
|
References (10)
|